|Bid||23.55 x 68800|
|Ask||23.56 x 1500|
|Day's Range||23.42 - 23.62|
|52 Week Range||16.48 - 26.97|
|PE Ratio (TTM)||28.75|
|Earnings Date||Nov 2, 2017 - Nov 8, 2017|
|Dividend & Yield||0.54 (1.93%)|
|1y Target Est||N/A|
Phocus Rx® is Live with Bidirectional Interfaces with Three of the Top Five Hospital Information Systems in the US BARCELONA, Spain , Aug. 22, 2017 /PRNewswire/ -- Phocus Rx ® enhances safety and improves ...
- American Red Cross is testing selected donations collected in areas of the U.S. that are endemic for the tick known to carry the Babesia parasite - The data collected will be used in the submission process ...
BARCELONA, Spain, June 22, 2017 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, and a leader in the development of innovative diagnostic solutions, is expanding its Texas-based Clinical Diagnostics Laboratory menu by launching therapeutic drug monitoring testing services. As the standard of care changes towards individualized patient care in diseases such as inflammatory bowel diseases, the clinicians' demand for monitoring biologic drugs is growing.